Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

The study’s findings highlight a potential risk factor for younger women with asthma considering their contraceptive options ...

While genetics can increase a person's likelihood of developing asthma, high pollution and exposure to harmful environmental ...

Asthma, a chronic respiratory disease affecting over 262 million people globally, poses a significant public health challenge ...

Imperial College London researchers say they may have found a crucial ‘piece to the puzzle’ why asthma is worse for women and ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

India reportedly has the highest asthma-related deaths in the world, accounting for nearly 46% of them. With over 34 million ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

A major study of around 260,000 women shows that taking the progesterone-only contraceptive pill can increase asthma attacks ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat ...